teva pharmaceutical industries news

Teva Pharma Q3 Beats Market, Lifts FY24 Outlook

Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript

Operator Hello, and welcome to the Q3 2024 Teva Pharmaceuticals Industries Limited earnings conference call. My name is Alex, I'll be coordinating the call today. [Operator instructions] I'll now hand over to your host,

Reuters · 22h

Teva Pharmaceutical sees more growth in 2025 after strong Q3

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance after beating third-quarter profit forecasts, boosted by strong sales of copycat medicines and its branded drugs to treat migraines and Huntington's disease.

Business Insider · 1d

Teva Pharma Q3 Beats Market, Lifts FY24 Outlook; Stock Up

(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) Wednesday reported a loss in its third quarter, compared to prior year's profit, despite higher revenues. However, adjusted earnings and top line beat market estimates, and the firm lifted its fiscal 2024 forecast.

Seeking Alpha on MSN · 23h

Teva gains after raising outlook for second time this year

Shares of Teva Pharmaceutical (NYSE:TEVA) gained in the premarket trading on Wednesday after the generic drugmaker reported better-than-expected Q3 2024 financials and raised its full-year outlook for the second time this year.

22h

Teva Pharm CEO says will work productively with Trump administration

Teva Pharmaceutical Industries expects to work productively with the incoming Trump administration in the United States, ...

ETF Daily News13h

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by QRG Capital Management Inc.

QRG Capital Management Inc. cut its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 1.6% during the third quarter, according to the company in its most recent ...

Teva Reports Strong Q3 2024 Financial Results

Teva Pharmaceutical Industries Limited ( (TEVA) ) has released its Q3 earnings. Here is a breakdown of the information Teva Pharmaceutical ...

21h

Teva Pharmaceutical Industries (TEVA) Reports Q3 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Teva Pharmaceutical Industries (TEVA) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some ...

Teva Pharmaceutical Industries (TEVA) Scheduled to Post Quarterly Earnings on Wednesday

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) will be announcing its earnings results before the market opens ...

Teva Hit With €463 Million EU Fine for Talking Down Rivals

Teva Pharmaceutical Industries Ltd. has been fined nearly €463 million ($503 million) by the European Union’s antitrust ...

Teva Pharmaceutical Industries Ltd (TEVA) Q3 2024 Earnings Call Highlights: Strong Revenue ...

Teva Pharmaceutical Industries Ltd (TEVA) reports a 15% revenue increase and raises 2024 guidance, despite facing legal and ...

5don MSN

Teva long-acting olanzapine shows improvements in schizophrenia patients

Data from a phase 3 trial of Teva Pharmaceutical Industries' (NYSE:TEVA) TEV-'749 indicated that the long-acting, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results